FDA Avoided Half Of ANDA Pre-Approval Inspections During COVID By Using Alternative Tools

 
• By Derrick Gingery
  
Files under review
Previous four fiscal quarters showed a more than 50% reduction in the PAI inspections that were needed. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from R&D

More from Pink Sheet